Delivery Order SPE2DB22D3501-SPE2DB24FXA05
Award Date
9/18/24
Potential Completion Date
9/19/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D2007|SPE2DB25FH9ZH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.44 firm-fixed-price delivery order is for the supply of QSYMIA 7.5 MG-46 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. This award is not designated as a set-aside contract....
This federal contract award, with the ID SPE2DX15D6028|SPE2DX24FWSXK, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $2,335.28 firm fixed-price delivery order is for the pharmaceutical product QSYMIA 3.75MG-23MG 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,478.55, is for the delivery of the pharmaceutical product QSYMIA 7.5MG-46MG 30S. It is a firm fixed-price Delivery Order with a completion date of July 12, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award (SPE2DB20D3303 | SPE2DB24FZ6U6) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,419.00 firm-fixed-price delivery order is for the supply of Qsymia 3.75 mg-23 mg capsules. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,324.07 firm fixed-price delivery order is for the provision of QSYMIA 7.5 MG-46 MG CAPSULE 30S, with a performance period extending through May 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Qsymia. The $3,501.18 Firm Fixed Price delivery order contract has an ultimate completion date of August 2, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical products and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, by the Defense Logistics Agency (DLA). The award is a $1,360.17 delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued up to $999,999,999 through December 2025. The contract is for the delivery of Qsymia 7.5 mg-46 mg capsules, a prescription medication. This order does not have a set-aside designation. Amerisourcebergen, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,239.78 firm-fixed-price delivery order is for the supply of the medication Qsymia in 3.75 mg-23 mg capsules. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568520731 - QSYMIA 3.75 MG-23 MG CAPSULE 30S, a prescription medication. The total ceiling value of the contract is $1,587.98, with a firm fixed price pricing type. The contract has an ultimate completion date of June 12, 2025. This appears to be a non-set-aside...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Qsymia 15mg-92mg in 30-count packages. The contract, valued at $2,990.04, is a delivery order with a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...